Skip to Content

How does Venclexta work?

Answers (1)

Official Answer by Drugs.com 5 May 2016

Venclexta (venetoclax) was FDA-approved in April 2016.

Venclexta, by AbbVie, is an oral B-cell lymphoma-2 (BCL-2) inhibitor for chronic lymphocytic leukemia (CLL) with 17p deletion. The 17p deletion is a chromosomal abnormality detected with a FDA-approved diagnostic test. The CLL cancer cell growth is fed by the BCL-2 protein, but Venclexta inhibits this protein.

In one study, 106 patients took increasing doses of the Venclexta pill once a day for five weeks. Results showed that 80% of patients either saw improvement or their cancer fully disappear.

Common side effects included low red and white blood cell count, diarrhea, nausea, and respiratory (lung) infections.

Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What is the Dsuvia REMS program?

Updated 24 hours ago 1 answerFAQ by Drugs.com

What type of drug is Lorbrena?

Updated 24 hours ago 1 answerFAQ by Drugs.com

What is the difference between Udenyca and Neulasta?

Updated 23 hours ago 1 answerFAQ by Drugs.com

How is the new Primatene Mist different to the old formulation?

Updated 23 hours ago 1 answerFAQ by Drugs.com

How do you use Yupelri inhalation solution?

Updated 23 hours ago 1 answerFAQ by Drugs.com